SBIR/STTR Research Award
NONPEPTIDE INHIBITORS OF ANTHRAX LETHAL FACTOR
Award amount
$100,000Program and phase
SBIR · Phase IAward year
1999Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- CENGENT THERAPEUTICS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Not Available New weapon capabilities identified for the 21st century include countering weapons of mass destruction (WMD) and non-explosive force projection. Current weapon systems do not have capabilities that can meet these objectives. High intensity acoustic weapons can meet any new requirements such as nonlethal effects and removing suspended WMD agents from the air. High intensity sound sources packaged into a compact, air delivered ordnance will provide the warfighter with an ability to counter many new threat scenarios. Prior acoustic weapons developed for ground operations don't meet the weight/volume restrictions for air delivered warhead missions. SARA proposed a seminal demonstration, at the laboratory level, of a compact, high energy, acoustic source that will be the key enabling technology in harnessing acoustic weapons for compact air delivered/air dispensed weapons. This technology (on follow on programs) when scaled up and fully integrated into a warhead will provide the ability to project nonlethal force and to control collateral chemical/biological agent releases.
Technology keywords
Not reported